We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

25 hedge funds and large institutions have $26.4M invested in TetraLogic Pharmaceuticals Corporation in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less funds holding

Funds holding: 2825 (-3)

30% less capital invested

Capital invested by funds: $37.7M → $26.4M (-$11.3M)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
25
Holders Change
-3
Holders Change %
-10.71%
% of All Funds
0.73%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
4
Reduced
6
Closed
8
Calls
Puts
Net Calls
Net Calls Change

TLOG Hedge Fund Activity: Q3 2014 in Review

25 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q3 2014, worth a combined $26.4M — down 30% from $37.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TLOG and 5 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Morgan Stanley, adding an estimated $109K. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $189K sold.

  • 25 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q3 2014, down from 28 in Q2 2014.
  • Funds reported $26.4M of TetraLogic Pharmaceuticals Corporation stock for Q3 2014, down 30% quarter-over-quarter.
  • 5 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q3 2014 and 8 closed out, a net change of -3 holders.
  • The largest TetraLogic Pharmaceuticals Corporation buyer in Q3 2014 was Morgan Stanley, an estimated $109K added.
  • The largest TetraLogic Pharmaceuticals Corporation seller in Q3 2014 was Driehaus Capital Management, an estimated $189K sold.

Based on aggregated 13F filings for Q3 2014.